Exchange: OTC·Updated 10:35 AM EDT
AMPE logo

AMPE Ampio Pharmaceuticals Inc

$0.1831
$0.4569
(71.39%)
Today
Mkt Cap$207,884.00
Vol1.00

About AMPE

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.
54

Neutral Sentiment

How do you feel about AMPE?

Advertisement|Remove ads.